JARI Pharmaceutical Co., Ltd, located in Lianyungang high & new technology area is a research, development, production and trade unit subordinate to JARI Group (Jiangsu Automation Research Institute). JARI Pharmaceutical has more than 200 staff members with various experts among whom there are 45 chemistry and medicine synthesis technicians. Assets of JARI Pharmaceutical amount to 50 millions and it covers an area of 70,000 square meters with more than 20,000 square meters floor space?with two plants.
Three facilities of the company separately manufacture raw materials, fine chemistry and formulations. JARI Pharmaceutical has medicine synthesis laboratory , structure laboratory and chemistry testing rooms with excellent experimentation equipments and various advanced analyzing apparatuses.
The company mainly undertakes research, development ,production in fields of chemistry raw materi-als, intermediates, special type of fine chemistry and their dosages and takes up with distilling in active matters of halobios and R&D in bioengineering technology.
JARI Pharmaceutical attaches importance to quality of products and carries through Total Quality Management according to Good Manufacturing Practice. Main products are Irinotecan Hydrochloride, Gemcitabine Hydrochloride, Decitabine, Fludarabine phosphate, Letrozole, Bicalutamide, Torsamide, Sorafenib, Febuxostat.
JARI Pharmacutical insists on the management principle of DEVELOP WITH THE DEMAND OF MAN-KIND?S HEALTH. We will research in new technology and develop new products in need for our customers. And we will make great efforts with all friends for a prosperous future for mankind?s health.